STX
45
-4
ICE
59
-3
HUM
41
-4
EXR
57
2
WBA
43
-4
TJX
62
-2
T
48
3
COST
57
-6
NI
72
4
MTB
65
-2
AMT
37
3
BDX
56
10
CTAS
53
-3
RIG
43
-7
LEN
50
-2
EA
60
-5
HSIC
45
5
KIM
72
2
CMS
60
2
SEE
53
3
STX
45
-4
ICE
59
-3
HUM
41
-4
EXR
57
2
WBA
43
-4
TJX
62
-2
T
48
3
COST
57
-6
NI
72
4
MTB
65
-2
AMT
37
3
BDX
56
10
CTAS
53
-3
RIG
43
-7
LEN
50
-2
EA
60
-5
HSIC
45
5
KIM
72
2
CMS
60
2
SEE
53
3
Financhill
Back

iShares Core Growth Allocation ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
46

AOR
iShares Core Growth Allocation ETF

Last Price:
57.97
Seasonality Move:
2.07%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
46
iShares Core Growth Allocation ETF (AOR) is a Sell

Is iShares Core Growth Allocation ETF a Buy, Sell or Hold?

  • The current iShares Core Growth Allocation ETF [AOR] share price is $57.98. The Score for AOR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AOR Stock Price Chart

What is iShares Core Growth Allocation ETF's stock price today?

  • The iShares Core Growth Allocation ETF share price today is $57.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AOR is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 42.5 Sell
Chaikin Money Flow: -63440 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.05 - 58.85) Sell
Bollinger Bands (100): (56.69 - 58.75) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.58 Sell
20-day SMA: 58.34 Sell
50-day SMA: 58.52 Sell
200-day SMA: 56.34 Buy
8-day EMA: 58.37 Sell
20-day EMA: 58.41 Sell
50-day EMA: 58.27 Sell
200-day EMA: 56.34 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares Core Growth Allocation ETF Earnings Growth & AOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares Core Growth Allocation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):